Full Text View
Tabular View
No Study Results Posted
Related Studies
High-density Lipoprotein (HDL) Cholesterol in Women Taking Tibolone (TibFen)
This study has been completed.
Study NCT00809068   Information provided by Keogh Institute for Medical Research

First Received on June 10, 2008.   Last Updated on January 31, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
HDL Cholesterol
Interventions listed in this trial
fenofibrate and tibolone
tibolone
Additional drug interventions recognized in this trial
Fenofibrate
More general drug interventions related to this trial
Anabolic Agents
Androgen Antagonists
Antihypertensive Agents
Antimetabolites
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Cardiovascular Agents
Estrogen Receptor Modulators
Hormone Antagonists
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Hypolipidemic Agents
Lipid Regulating Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Keogh Institute for Medical Research


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services